RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC

Clinical trial NCT04849377 · WITHDRAWN

Trial details

NCT number: NCT04849377
Sponsor: Icahn School of Medicine at Mount Sinai
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Human Papillomavirus (HPV)Head and Neck Squamous Cell Carcinoma (HNSCC)

Start date: 2022-06-14
Primary completion: 2022-06-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.